CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,484 | $72.64 | $326K | 679,680 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −3,994 | $73.25 | $293K | 675,686 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,860 | $70.70 | $556K | 4,490,587 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −3,775 | $71.46 | $270K | 4,486,812 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,404 | $72.65 | $320K | 4,482,408 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −3,961 | $73.25 | $290K | 4,478,447 |
| 2026-02-10 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,201 | $71.80 | $1.0M | 701,485 |
| 2026-02-10 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,799 | $72.28 | $419K | 695,686 |
| 2026-02-10 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,040 | $71.80 | $1.0M | 4,504,407 |
| 2026-02-10 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,960 | $72.27 | $431K | 4,498,447 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,151 | $75.75 | $163K | 733,535 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −6,955 | $76.72 | $534K | 726,580 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −10,519 | $77.61 | $816K | 716,061 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −375 | $78.19 | $29K | 715,686 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,401 | $75.61 | $106K | 4,537,046 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −6,067 | $76.53 | $464K | 4,530,979 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −10,677 | $77.46 | $827K | 4,520,302 |
| 2026-01-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,855 | $78.10 | $145K | 4,518,447 |
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,515 | $73.64 | $848K | 744,171 |
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,085 | $74.38 | $601K | 736,086 |
Page 10 of 19 · 379 trades